GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savior Lifetec Corp (ROCO:4167) » Definitions » Additional Paid-In Capital

Savior Lifetec (ROCO:4167) Additional Paid-In Capital : NT$135 Mil(As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Savior Lifetec Additional Paid-In Capital?


Savior Lifetec's quarterly additional paid-in capital stayed the same from Sep. 2024 (NT$135 Mil) to Dec. 2024 (NT$135 Mil) and stayed the same from Dec. 2024 (NT$135 Mil) to Mar. 2025 (NT$135 Mil).

Savior Lifetec's annual additional paid-in capital increased from Dec. 2022 (NT$134 Mil) to Dec. 2023 (NT$135 Mil) but then stayed the same from Dec. 2023 (NT$135 Mil) to Dec. 2024 (NT$135 Mil).


Savior Lifetec Additional Paid-In Capital Historical Data

The historical data trend for Savior Lifetec's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Savior Lifetec Additional Paid-In Capital Chart

Savior Lifetec Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 573.78 132.67 133.94 135.13 135.13

Savior Lifetec Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 135.13 135.13 135.13 135.13 135.13

Savior Lifetec Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Savior Lifetec Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Savior Lifetec's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Savior Lifetec Business Description

Traded in Other Exchanges
N/A
Address
No. 29, Kezhong Road, Hsinchu Science Park, Zhunan Township, Miaoli, TWN, 350
Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services. The company geographically operates in four regions such as the Americas, Asia, Taiwan, and Europe.

Savior Lifetec Headlines

No Headlines